Profile: AFG Biosolutions, Inc. is a biotechnology company that develops and produces recombinant proteins for therapeutic applications. We also develop antibodies against biological weapons, threats such as anthrax, smallpox, plague and tularemia into the area of naturally occurring infectious diseases. We use our Rev-VAT Platform to develop antibodies and vaccines that offer added value by reducing the risk of chronic diseases in which infection & inflammation are risk factors. We also provide our recombinant products as cGMP biological APIs for use in biosimilar therapeutics. We offer interferon alpha2a , interferon alpha2b and interferon gamma1b.